We grant share-based compensation awards to our officers, directors, and certain key employees pursuant to the 2017 Viad Corp Omnibus Incentive Plan (the “2017 Plan”). The 2017 Plan has a 10-year term and provides for the following types of awards: (a) incentive and non-qualified stock options; (b) restricted stock awards and restricted stock units; (c) performance units or performance shares; (d) stock appreciation rights; (e) cash-based awards; and (f) certain other stock-based awards. In June 2017, we registered 1,750,000 shares of common stock issuable under the 2017 Plan. As of December 31, 2021, there were 672,648 shares available for future grant under the 2017 Plan.

The following table summarizes share-based compensation (income) expense:


	Year Ended December 31,
(in thousands)	2021			2020			2019
Performance-based restricted stock units	$	549		$	(2,187	)	$	3,990
Restricted stock awards and restricted stock units		5,451			4,523			3,200
Stock options		1,727			317			—
Share-based compensation expense before income tax		7,727			2,653			7,190
Income tax benefit(1)		(82	)		—			(2,241	)
Share-based compensation expense, net of income tax	$	7,645		$	2,653		$	4,949

(1)

The 2021 income tax benefit amount primarily reflects the tax benefit associated with our Canadian-based employees. There was no income tax benefit in 2020 associated with our employees in the United States and the United Kingdom due to a valuation allowance on our deferred tax assets within these jurisdictions. Refer to Note 17 – Income Taxes.

We recorded no share-based compensation expense through restructuring charges in 2021 or 2020, and $0.1 million in 2019. No share-based compensation costs were capitalized during 2021, 2020, or 2019.

Performance-based restricted stock units (“PRSUs”) are tied to our stock price and the expected achievement of certain performance-based criteria. The vesting of PRSUs is based upon the achievement of the performance-based criteria over a three to four-year period. We account for PRSUs that will be settled in shares of our common stock as equity-based awards. We measure share-based compensation

expense of equity-based awards at fair value on the grant date on a straight-line basis over the vesting period. The estimated number of units to be achieved is updated each reporting period.

We account for PRSUs that will be settled in cash as liability-based awards. We measure share-based compensation expense of liability-based awards at fair value at each reporting date until the date of settlement. Forfeitures are recorded when they occur.

During the year ended December 31, 2021, we granted PRSUs with a grant date fair value of $3.2 million, all of which are payable in shares.

In 2021, PRSUs granted in 2018 vested; however, as performance metrics were not achieved, no awards were paid in cash or in shares. In 2020, PRSUs granted in 2017 vested and we paid $2.6 million in cash. No PRSUs were paid in shares in 2020. In 2019, PRSUs granted in 2016 vested and we paid $5.6 million in cash and $3.4 million in shares. In 2019, we withheld 25,771 shares for $1.5 million related to tax withholding requirements on vested PRSUs paid in shares.

As of December 31, 2021, the unamortized cost of outstanding equity-based PRSUs was $2.5 million, which we expect to recognize over a weighted-average period of approximately 2.5 years. Liabilities related to liability-based PRSUs were $0.7 million as of December 31, 2021 and $0.8 million as of December 31, 2020.

The following table summarizes the activity of the outstanding PRSU awards:


	Equity-Based PRSUs					Liability-Based PRSUs
	Shares			Weighted-Average Grant Date Fair Value		Shares			Weighted-Average Grant Date Fair Value
Balance at December 31, 2020		61,208		$	57.18		121,485		$	56.34
Granted		101,785		$	31.28		—		$	—
Vested		—		$	—		(42,698	)	$	51.96
Forfeited		(28,841	)	$	58.25		(1,041	)	$	56.90
Balance at December 31, 2021		134,152		$	37.30		77,746		$	57.13

Restricted stock awards and restricted stock units are service-based awards. We account for restricted stock awards and restricted stock units that will be settled in shares of our common stock as equity-based awards. We measure share-based compensation expense of equity-based awards at fair value on the grant date on a straight-line basis over the vesting period.

We account for restricted stock units that will be settled in cash as liability-based awards. We measure share-based compensation expense of liability-based awards at fair value at each reporting date until the date of settlement. Forfeitures are recorded when they occur.

As of December 31, 2021, the unamortized cost of outstanding equity-based restricted stock awards and restricted stock units was $6.3 million, which we expect to recognize over a weighted-average period of approximately 1.2 years. We repurchased 37,686 shares for $1.6 million during 2021, 42,185 shares for $1.7 million during 2020, and 24,995 shares for $1.5 million in 2019 related to tax withholding requirements on vested share-based awards.

Aggregate liabilities related to liability-based restricted stock units were $0.2 million as of both December 31, 2021 and December 31, 2020. In 2021, 3,174 restricted stock units vested, and we paid $0.1 million in cash. In 2020, 2,815 restricted stock units vested, and we paid $0.2 million in cash and $2.0 million in shares. In 2019, 9,250 restricted stock units vested, and we paid $0.6 million in cash and $0.2 million in shares.

The following table summarizes the activity of the outstanding restricted stock awards and restricted stock units:


	Equity-Based Restricted Stock Awards					Equity-Based Restricted Stock Units					Liability-Based Restricted Stock Units
	Shares			Weighted-Average Grant Date Fair Value		Shares			Weighted-Average Grant Date Fair Value		Shares			Weighted-Average Grant Date Fair Value
Balance at December 31, 2020		107,107		$	53.23		151,261		$	19.51		10,459		$	51.91
Granted		22,560		$	44.77		155,110		$	43.24		—		$	—
Vested		(50,596	)	$	49.92		(60,905	)	$	19.54		(3,174	)	$	52.24
Forfeited		(2,279	)	$	56.63		(6,278	)	$	25.09		(1,007	)	$	37.20
Balance at December 31, 2021		76,792		$	52.83		239,188		$	34.74		6,278		$	55.93

We grant non-qualified stock options that are performance-based, as well as non-qualified stock options that are service-based. The performance-based awards are recognized on a straight-line basis over the performance period ranging from 1.4 to 3.4 years, and the underlying shares expected to be settled are adjusted each reporting period based on estimated future achievement of the respective performance metrics. The service-based awards are recognized on a straight-line basis over the requisite service period on a graded-vesting schedule ranging from one to three years.

The following table summarizes stock option activity:


	Shares			Weighted-Average Exercise Price		Aggregate Intrinsic Value(1)
Options outstanding at December 31, 2020		204,150		$	19.98
Granted		137,858		$	44.80
Exercised		—		$	—
Forfeited		(30,000	)	$	19.30
Options outstanding at December 31, 2021		312,008		$	31.01	$	3,952,701
Options exercisable at December 31, 2021		27,075		$	21.85	$	566,951

(1)

The aggregate intrinsic value of stock options outstanding represents the difference between our closing stock price at the end of the reporting period and the exercise price, multiplied by the number of in-the-money stock options.

The following table summarizes stock options outstanding and exercisable as of December 31, 2021:


	Options Outstanding						Options Exercisable
Range of exercise prices	Shares		Weighted-Average Remaining Contractual Life (in years)		Weighted-Average Exercise Price		Shares		Weighted-Average Exercise Price
$19.30		120,000		7.00	$	19.30		—	$	—
$21.85		54,150		5.65	$	21.85		27,075	$	21.85
$44.80		137,858		6.15	$	44.80		—	$	—
$19.30 - $44.80		312,008		6.39	$	31.01		27,075	$	21.85

The fair value of stock options granted in 2021 was estimated on the date of grant using the Black-Scholes stock option pricing model.

Following is additional information on stock options granted during 2021 and the underlying assumptions used in assessing fair value:


	Year Ended
	December 31, 2021
Assumptions used to estimate fair value of stock options granted:
Risk-free interest rate		0.5	%
Expected term (in years)		4.5
Expected volatility		55.8	%
Expected dividend yield		—
Weighted average grant-date fair value per share of options granted	$	20.26

As of December 31, 2021 and 2020, the total unrecognized compensation cost related to non-vested stock option awards was $1.4 million. We expect to recognize such costs over a weighted-average period of approximately 1.5 years.